Advertisement
Screener

IVERIC bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value

IVERIC bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value

IVERIC bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $66.27 million as of 2022-12-31, per its 10-K filed 2023-03-01.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2023-03-01

  • 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $66.27M.
  • 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $56.99M.
  • 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $11.74M.
  • 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $10.56M.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
2022-12-31$66.27M
10-K · filed 2023-03-01
2021-12-31$56.99M
10-K · filed 2022-02-24
2020-12-31$11.74M
10-K · filed 2021-03-04
2019-12-31$10.56M
10-K · filed 2020-02-27
2018-12-31$3.00K
10-K · filed 2019-02-28
2018-09-30$44.00K
10-Q · filed 2018-11-02
2018-06-30$71.00K
10-Q · filed 2018-08-01
2018-03-31$69.00K
10-Q · filed 2018-05-09
2017-12-31$122.00K
10-K · filed 2018-03-05
2017-09-30$95.00K
10-Q · filed 2017-11-08
2017-06-30$78.00K
10-Q · filed 2017-08-02
2017-03-31$141.00K
10-Q · filed 2017-05-03
2016-12-31$254.00K
10-K · filed 2017-02-28
2016-09-30$23.08M
10-Q · filed 2016-11-08
2016-06-30$29.17M
10-Q · filed 2016-08-05
2016-03-31$19.09M
10-Q · filed 2016-05-09
2014-09-30$41.52M
10-Q · filed 2014-11-12